| 摘要 |
<p>A process is disclosed for the preparation of (1) by reduction of (2) directly using catalytic transfer hydrogenation to suppress formation of (4) or by cnventional reduction via (4). Compound (1) is a key intermediate for inter alia paroxetine.</p> |
